Help us: Donate
Follow us on:
×

Menu

Back

Kevin Strange at Ending Age-Related Diseases 2019

Kevin Strange at EARD2019Kevin Strange at EARD2019

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

Kevin Strange discussed his company, Novo Biosciences, and how it is developing small molecules that restore the body’s ability to regenerate. He went into detail about how humans begin life with this ability but lose it as they age. He discussed MSI-1436, which is a prospective drug for reversing ischemic heart injury and making life easier for survivors of heart attack as well as reversing skeletal muscle degeneration.

HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Lifespan.io YouTube
Lifespan.io Facebook
Lifespan.io Twitter
Lifespan.io Instagram
Lifespan.io Instagram
Lifespan.io Discord
Thank You!

About the author
Josh Conway

Josh Conway

Josh is a professional editor and is responsible for editing our articles before they become available to the public as well as moderating our Discord server. He is also a programmer, long-time supporter of anti-aging medicine, and avid player of the strange game called “real life.” Living in the center of the northern prairie, Josh enjoys long bike rides before the blizzards hit.
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.